The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer
NCT05704231 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2023-01-30
Summary
This study will be carried out to examine the effect of telephone-assisted smoking cessation program on self-efficacy, smoking behavior, tumor recurrence and progression in patients with non-muscle invasive bladder cancer.
Conditions
- Non-Muscle Invasive Bladder Cancer
- Self Efficacy
- Smoking Behaviors
- Tumor Recurrence
- Progression, Disease
Interventions
- BEHAVIORAL
-
Behavioral: Motivational Interviewing with WhatsApp video call
The intervention group will be given a motivational interview with a WhatsApp video call for 3 months. Motivational interviews will be applied every two weeks, 6 times in total.
Sponsors & Collaborators
-
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
lead OTHER_GOV
Principal Investigators
-
İrem Nur Özdemir, PhD, RN · Bakırköy Dr. Sadi Konuk
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-01
- Primary Completion
- 2024-03-01
- Completion
- 2024-06-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Outcome of Treating Bladder Cancer in Sohag University Hospital
NCT05082818 ·Status: COMPLETED
-
The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression
NCT04617743 ·Status: UNKNOWN
-
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
NCT00777491 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations
NCT04900259 ·Status: COMPLETED
-
En-Bloc Resection of Bladder Tumors
NCT04784507 ·Status: UNKNOWN ·Phase: PHASE2
-
sEphB4-HSA in Treating Participants With BCG-Unresponsive or Refractory Bladder Cancer
NCT03552796 ·Status: WITHDRAWN ·Phase: PHASE1
-
Neoadjuvant Chemotherapy in Non Muscle Invasive T1b Bladder Cancer
NCT04245618 ·Status: UNKNOWN
-
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
NCT07225127 ·Status: RECRUITING
-
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
NCT06350734 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Tumor Base Size in Bladder Cancer
NCT06632340 ·Status: COMPLETED ·Phase: NA
-
Intravesical Thermochemotherapy With Mitomycin-c
NCT03694535 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation
NCT05084586 ·Status: UNKNOWN ·Phase: NA
-
The iBlad App - a National, Exploratory Study on a Multimodality Smartphone App for Bladder Cancer Patients
NCT05710159 ·Status: RECRUITING
-
Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG
NCT05672615 ·Status: RECRUITING
-
Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression
NCT02443844 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study
NCT05626101 ·Status: RECRUITING ·Phase: NA
-
Clinicoepidimiological Study and Clinical Outcome in Patients With Urinary Bladder Cancer
NCT04525781 ·Status: UNKNOWN
-
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
NCT06138561 ·Status: RECRUITING
-
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
NCT01050504 ·Status: RECRUITING
-
Impact of Time to Re-staging Transurethral Resection on Recurrence and Progression Rates
NCT04768894 ·Status: COMPLETED ·Phase: NA
-
sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer
NCT02767921 ·Status: TERMINATED ·Phase: PHASE1
-
Ileal Conduit Versus Cutaneous Ureterostomy After Radical Cystectomy
NCT04610385 ·Status: UNKNOWN
-
Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery
NCT02944357 ·Status: WITHDRAWN ·Phase: NA
-
A Study to Evaluate Treatment Preferences for Japanese Participants With Muscle-invasive Urothelial Carcinoma of the Bladder
NCT05742867 ·Status: COMPLETED
-
Role of Hypofractionated Radiotherapy With Concurrent Gemcitabine in Treatment of Urinary Bladder Carcinoma
NCT04812145 ·Status: UNKNOWN